Treating KRAS-mutant NSCLC: latest evidence and clinical consequences

Therapeutic Advances in Medical Oncology
Pilar GarridoJosé Palacios

Abstract

KRAS mutations represent one of the most prevalent oncogenic driver mutations in non-small cell lung cancer (NSCLC). For many years we have unsuccessfully addressed KRAS mutation as a unique disease. The recent widespread use of comprehensive genomic profiling has identified different subgroups with prognostic implications. Moreover, recent data recognizing the distinct biology and therapeutic vulnerabilities of different KRAS subgroups have allowed us to explore different treatment approaches. Small molecules that selectively inhibit KRAS G12C or use of immune checkpoint inhibitors based on co-mutation status are some examples which anticipate that personalized treatment for this challenging disease is finally on the horizon.

References

Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ming-Sound TsaoFrances A Shepherd
Sep 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gregory J RielyMarc Ladanyi
Oct 25, 2008·Nature·Li DingRichard K Wilson
Dec 21, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M C GarassinoM Broggini
Jan 17, 2012·Journal of the National Cancer Institute·Nathan T IhleGarth Powis
Jan 24, 2012·The European Respiratory Journal·Chiara ScocciantiUNKNOWN European Early Lung Cancer Consortium
Jul 10, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Giulio MetroLucio Crinò
Apr 24, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Daquan MengJianbao Xin
May 1, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frances A ShepherdMing-Sound Tsao
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Aug 15, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Benjamin IzarMichael Lanuti
Aug 30, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Ernest NadalNithya Ramnath
Nov 22, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Helena A YuGregory J Riely
Feb 28, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G R BlumenscheinP A Jänne
Mar 5, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Antonio CallesPasi A Jänne
Jun 2, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Min YingLong-Hua Chen
Sep 16, 2015·British Journal of Cancer·Stéphane RenaudGilbert Massard
Oct 17, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Antonio CallesPasi A Jänne
Dec 15, 2015·The Journal of Clinical Investigation·Mick D EdmondsChristine M Eischen
Dec 31, 2015·Expert Review of Respiratory Medicine·Biagio RicciutiLucio Crinò
Jan 10, 2016·Molecular Cancer Research : MCR·Oliver A KentRobert Rottapel
Jan 11, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Alona ZerFrances A Shepherd
Mar 10, 2016·Cancer Discovery·Kenneth D WestoverNathanael S Gray
May 21, 2016·Cancer Research·Stephanie LangschErik Vassella
May 26, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ke-Jing TangPier Paolo Scaglioni
Nov 4, 2016·Nature Reviews. Drug Discovery·Jonathan M L Ostrem, Kevan M Shokat

❮ Previous
Next ❯

Citations

Aug 11, 2018·Oncotarget·Florian JankerWolfgang Jungraithmayr
Sep 5, 2020·Cancer Management and Research·Hai-Bo ShenTian-Jun Hu
Oct 27, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy F BurnsSolange Peters
Jul 8, 2019·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Le Van Manh HungSomi Kim Cho
Aug 4, 2020·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Francesco PassigliaSilvia Novello
Mar 12, 2019·Current Medicinal Chemistry·Sitanshu S SinghSeetharama D Jois
May 12, 2021·Proceedings of the National Academy of Sciences of the United States of America·Jean Ching-Yi TienArul M Chinnaiyan
Mar 25, 2020·The Journal of Molecular Diagnostics : JMD·Kaat Van CasterenUNKNOWN International Quality Network for Pathology ctDNA Working Group and the European Society of Pathology Foundation Assessors

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

The American Journal of Managed Care
Jill M ComeauBrice Labruzzo Mohundro
Zhongguo fei ai za zhi = Chinese journal of lung cancer
Yang Li
Annals of Oncology : Official Journal of the European Society for Medical Oncology
J X ZhouJ He
Translational Lung Cancer Research
Konstantinos Leventakos, Aaron S Mansfield
© 2022 Meta ULC. All rights reserved